XLV vs TMED
YTDYear to date
XLV wins+5.1 pts
Past year
XLV wins+8.6 pts
Fee
XLV winslower fee
Yield
XLV wins+0.9 pts
AUM
XLV1389.1× more
4–0XLV wins
XLV and TMED · year-to-date · as of Nov 5, 2026 · AUM not scored
TMED vs S&P 500
3M$35.35 · +2.4% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3M ▼YTD1Y3Y5YMAX
Total return+2.4%+6.4%+2.0%+18.9%+24.9%——+41.5%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
T. Rowe Price TMED and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
TMED’s Holdings
TodayLLY.TOEli Lilly +6.1%UNH.BA5.2%PODD3.9%ALNY3.6%TMO.TO3.4%GILD.TO3.2%A3.0%ISRG3.0%ELAN2.9%COR2.5%DHR2.4%ASND2.4%WST2.3%CYTK2.2%DXCM2.1%WAT2.1%PCVX2.1%DYN1.8%IDXX1.8%DNLI1.8%BSX1.7%ABT1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsOther
T. Rowe Price TMED · 0 holdings · tile size = share of the fund · as of Nov 4, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +24.0% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +23.3% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +30.6% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +23.7% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +23.4% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +71.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +29.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +27.1% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +26.0% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +36.8% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +20.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +26.8% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +26.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +38.2% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
TMED Payouts by Year
1YLatest payout, Dec 2025
$0.16
a share
0.5% yield
0.5% yield
1 years added up
$0.16 a share
$0.16 a share
T. Rowe Price TMED · per-share distributions by ex-date · 2025–2025
TMED’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | TMED | T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFThis fund | 0.44% | 0.5% | +2.4% | +18.9% | +24.9% | $35.4M |
#22 of 33 this year · #20 cheapest of 39 · sorted by assetsOpen the Sectors table →
TMED and its peer group · total return · as of Nov 5, 2026
Cards for This View
TMED’s Top 10 Holdings
Today36.8%of TMED sits in these 10
6GILD.TGilead Sciences 0013.15%
T. Rowe Price TMED · weight in the fund · as of Nov 4, 2026
TMED’s Holdings
TodayLLY.TOEli Lilly +6.1%UNH.BA5.2%PODD3.9%ALNY3.6%TMO.TO3.4%GILD.TO3.2%A3.0%ISRG3.0%ELAN2.9%COR2.5%DHR2.4%ASND2.4%WST2.3%CYTK2.2%DXCM2.1%WAT2.1%PCVX2.1%DYN1.8%IDXX1.8%DNLI1.8%BSX1.7%ABT1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsOther
T. Rowe Price TMED · 0 holdings · tile size = share of the fund · as of Nov 4, 2026
TMED vs Peer Average
YTDTMEDAvsBPeer average
1D+2.4%+2.7%
1M+6.4%+8.5%
3M+2.0%+8.9%
YTD+18.9%+24.4%
1Y+24.9%+33.4%
3Y[…]+84.3%
5Y[…]+34.0%
0–5Peer average wins
38 Health care peers · each row scaled to its leader